New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 5, 2014
07:17 EDTCYCCCyclacel Pharmaceuticals issued new Japanese patent
Cyclacel Pharmaceuticals announced that the Japanese Patent and Trademark Office issued two patents broadening the exclusivity of sapacitabine, the company's lead clinical candidate. Japanese Patent 5443763 claims novel pharmaceutical formulations of sapacitabine. Japanese Patent 5457196 claims methods of treating cancer comprising sapacitabine in combination with histone deacetylase inhibitors. Equivalent patents have been granted in the United States and other countries.
News For CYCC From The Last 14 Days
Check below for free stories on CYCC the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for CYCC

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use